John Yates

1.9k citations
10 papers · 1.5k indexed · 2 hit papers · h-index 9
Topics
Cancer, Lipids, and Metabolism (4 papers)Peroxisome Proliferator-Activated Receptors (3 papers)Lipoproteins and Cardiovascular Health (3 papers)

In The Last Decade

John Yates

10 papers receiving 1.4k citations

Hit Papers

Selective small molecule inhibitors of glycogen synthase ...200020262008201720002014250500750

Peers

John Yates
Comparison fields: 5 of 96
  • Molecular Biology 918
  • Oncology 363
  • Hematology 229
  • Radiology, Nuclear Medicine and Imaging 167
  • Surgery 151
Replace Sharmistha Chakraborty with:
Sharmistha Chakraborty United States
Candy Robinson United States
Fengjuan Fan China
Péter Ács United States
Yosuke Matsushita Japan
V. Poulaki United States
Safiyyah Ziyad United States
Wenqing Yao United States
Anna Garuti Italy
Alykhan Motani United States
John Yates relative to Sharmistha Chakraborty United States Sharmistha Chakraborty's profile →
Citations per field
00.5×4.6×
Sharmistha Chakraborty · 1×
Citations per year

Countries citing papers authored by John Yates

Since Specialization
Citations

This map shows the geographic impact of John Yates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Yates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Yates more than expected).

Fields of papers citing papers by John Yates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Yates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Yates. The network helps show where John Yates may publish in the future.

Co-authorship network of co-authors of John Yates

This figure shows the co-authorship network connecting the top 25 collaborators of John Yates. A scholar is included among the top collaborators of John Yates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Yates. John Yates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 8
2
Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myelomabreakdown →
375
3 90
4
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcriptionbreakdown →
771
5 26
6 124
7
Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
28
8 19
9 1
10 29

About John Yates

John Yates is a scholar working on Cancer Research, Biochemistry and Biotechnology, having authored 10 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). The work is most often cited by research in Hematology (229 citations), Molecular Biology (918 citations) and Oncology (363 citations). John Yates has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Neil Pearce, Gregory Murphy, Matthew P. Coghlan, Julie C. Holder, Stacey L. Corcoran, Kenneth Murray, Darren A.E. Cross, David Haigh, Oliver Rausch and Murray J. B. Brown. Their work appears in journals such as Blood, Biochemical Journal and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026